0.00Open3.19Pre Close0 Volume4 Open Interest6.00Strike Price0.00Turnover200.25%IV-2.80%PremiumAug 16, 2024Expiry Date3.46Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8763Delta0.0404Gamma2.78Leverage Ratio-0.0210Theta0.0031Rho2.44Eff Leverage0.0052Vega
SIGA Technologies Stock Discussion
SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company, has recently announced that the U.S. Department of Health and Human Services (HHS) has exercised a procurement option, resulting in an order worth approximately $113 million for oral TPOXX® treatment courses. $SIGA Technologies(SIGA.US)$
https://stockregion.app/p/pharmaceutical-technology-company
loading...
loading...
In a recent announcement that has stirred the world of biotechnology and pharmaceuticals, SIGA Technologies Inc., an American company known for its groundbreaking work in the development and commercialization of solutions for serious unmet medical needs and biothreats, has declared a special cash dividend of $0.60 per share. $SIGA Technologies(SIGA.US)$